Abstract:OBJECTIVE: To explore the feasibility of treating cirrhosis using a multidisciplinary team approach (MDT) and to pinpoint the key factors influencing its implementation.METHODS: The data of 307 patients with decompensated cirrhosis were studied retrospectively. Patients who received more than two treatment measures were assigned to the MDT group (n=228), and patients who received symptomatic medical drug treatment only were assigned to the traditional treatment group (n=79). The follow-up period ranged from 4 to 10 years, and the average follow-up period was 5.7 years. The results of the biochemical tests for hepatitis B virus deoxyribonucleic acid, hepatitis C virus ribonucleic acid, and autoantibodies to liver disease were analyzed.RESULTS: The differences in gender and Child-Pugh grade of liver function between the two groups were not statistically significant. The MDT group had obvious advantages over the traditional treatment group in occupational composition, etiology composition, 5-year survival rate and annual hospitalization times. The leading causes of death in the MDT group, in descending order, were liver cancer, infection, mesenteric thrombosis, and non-hepatic disease, and, in the medical treatment group, they were liver failure, gastrointestinal bleeding, infection, and liver cancer. There was a significant statistical difference between the two groups (p < 0.05). In the multidisciplinary treatment, etiological treatment was the most widely used treatment, accounting for 79.8%, followed by endoscopic treatment (33.3%), peritoneal drainage and ascites reinfusion (25%), splenectomy combined with devascularization (11.4%) and stem cell transplantation and liver transplantation (1.8%).CONCLUSION: An MDT can improve the efficacy and prognosis of patients with cirrhosis and improve patient compliance. After multi-disciplinary intervention, the mortality spectrum of long-term survival patients with cirrhosis changes, and the mortality rate of liver cancer and non-liver disease increases.

Model of Hepatocellular Carcinoma Multidisciplinary Team

Expert Consensus on Organizing the Multidisciplinary Team(mdt) Diagnosis and Treatment of Hepato-Pancreato-biliary Diseases in China

Based on Tumor Mutation Burden to construct diagnosis and prognosis models and provides guidance for the treatment in the Hepatocellular Carcinoma patients

Pay Attention to Multidisciplinary Team (MDT) for Diagnosis and Treatment of the Malignant Tumor in General Surgery

Multidisciplinary Team Diagnosis and Treatment of Hilar Cholangiocarcinoma

The Exploration of Multidisciplinay Team (MDT) for Digestive System Cancer in Beijing Cancer Hospital

Impact of multidisciplinary team working on the management of colorectal cancer.

Attaching importance to the effect of multidisciplinary team in the standardized treatment of gastric cancer

[Multidisciplinary Team Model for Patients with Oral Cancer and Systemic Diseases: an Expert Consensus].

Colorectal Cancer Multidisciplinary Team Working Pattern

The setting of multidisciplinary team for colorectal liver metastasis

Application of Multi-Disciplinary Team in the Diagnosis and Treatment of Metastatic Colorectal Cancer

Multidisciplinary team for rectal cancer

[Current Situation and Future Direction of Multidisciplinary Diagnosis and Treatment of Lung Cancer]

Effect of multidisciplinary team care on patient survival in chronic hepatitis B or C hepatocellular carcinoma

The Multidisciplinary Team (MDT) Approach and Quality of Care

A Multidisciplinary Team Approach to the Treatment of Liver Cirrhosis

The multidisciplinary management of gastric cancer: Experience from a tertiary comprehensive hospital in Shanghai, China

MDT is Still Important in the Treatment of Early Stage Lung Cancer

The Improved Effects Of A Multidisciplinary Team On The Survival Of Breast Cancer Patients: Experiences From China

<p>Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives</p>